Tradestie Institutional Equity Comparison Engine

BCAX vs TBPH โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

TBPH Overall Edge

TBPH Captures Institutional Edge (4โ€“0 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Theravance Biopharma, Inc. (TBPH) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, BCAX trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus TBPH at 13.4x Forward P/E and 8.9% operating margin (-20.9% YoY). In options structure, BCAX sits in BREAKDOWN (23rd %ile IV; Dealer Gamma Walls on Pro) against TBPH sits in UNCLASSIFIED (16th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner TBPH
BCAX N/M vs TBPH 13.4x Fwd P/E
Growth & Margin Winner TBPH
Op Margin 0.0% vs 8.9% ยท YoY +0.0% vs -20.9%
Momentum & Technical Winner TBPH
1Y -31.6% vs +21.0% ยท 52W Pos 8% vs 50%
Options & Structure Winner TBPH
BREAKDOWN (23rd %ile IV) vs UNCLASSIFIED (16th %ile IV)
BCAX NASDAQ
Bicara Therapeutics Inc. Common Stock
Pharmaceutical Preparations
$9.75
-2.69% 1D
Market Cap $665.2M
1M Return -41.9%
1Y Return -31.63%
Forward P/E N/M
Unified AI Score
52.1 / 100 HOLD
Tech 58.0 Fund 66.0 Flow 68.0 Mom 64.0
TBPH NASDAQ
Theravance Biopharma, Inc.
Pharmaceutical Preparations
$17.03
+0.0% 1D
Market Cap $884.2M
1M Return +0.12%
1Y Return +21.04%
Forward P/E 13.4x
Unified AI Score
54.9 / 100 HOLD
Tech 65.0 Fund 52.0 Flow 50.0 Mom 35.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: BCAX -31.63% TBPH +21.04% Spread: +48.78 pp (BCAX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
BCAX TTM Op. Margin: 0.0% TBPH TTM Op. Margin: 8.9%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BCAX vs TBPH. Trailing 12-month operating profitability (BCAX 0.0% vs TBPH 8.9%) and valuation multiples (BCAX N/M vs TBPH 13.4x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: BCAX (1) vs TBPH (9)
Institutional Metric BCAX TBPH Criterion Row Winner
Market Capitalization Scale $665.2M $884.2M Larger Scale TBPH
Trailing P/E Ratio Valuation N/M 16.4x Lower Multiple TBPH
Forward P/E Ratio Valuation N/M 13.4x Lower Multiple TBPH
Revenue Growth (YoY) Growth +0.0% -20.9% Higher Growth BCAX
Operating Margin (TTM) Profitability 0.0% 8.9% Higher Margin TBPH
Net Profit Margin Profitability 0.0% 51.6% Higher Margin TBPH
Return on Equity (ROE) Capital Efficiency -54.2% 20.9% Higher ROE TBPH
52-Week Range Position Momentum 8% ($8โ€“$31) 50% ($13โ€“$21) Stronger Trend TBPH
Beta / 30D Volatility Risk Regime 1.42ฮฒ ยท 184% Vol 0.48ฮฒ ยท 2% Vol Lower Realized Risk TBPH
Unified Institutional Score Composite Signal 52.1 / 100 (HOLD) 54.9 / 100 (HOLD) Higher Composite TBPH

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full BCAX vs TBPH Buy Guide
BCAX BREAKDOWN
93d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 23rd %ile
IV Regime Compressed (<25th %ile)
Live BCAX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
TBPH UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 16th %ile
IV Regime Compressed (<25th %ile)
Live TBPH Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither BCAX nor TBPH registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.